Providing market research reports, industry analysis, company profiles and country reports for strategic planning, competitive intelligence, marketing and business research.
Search for Market Research Reports:    

Netherlands Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Published by: Global Markets Direct

Published: Sep. 28, 2009 - 69 Pages


Table of Contents


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 Drug Delivery Devices
3.2 Inhalation Systems
3.2.1 Metered Dose Inhaler
3.2.2 Dry Powder Inhaler
3.3 Infusion Systems
3.3.1 Infusion Pumps
3.3.2 Syringe Pumps
3.3.3 Disposable Infusion Sets
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
4.3.1 Health Insurance Act
4.3.2 Healthcare Allowance Act
4.3.3 The Exceptional Medical Expenses Act
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification of Medical Devices
5.1.2 Conformity Assessment Process
5.1.2.1 Class I devices
5.1.2.2 Class IIa devices
5.1.2.3 Class IIb devices
5.1.2.4 Class III devices
5.2 Post Market Surveillance (PMS)
6 Pricing and Reimbursement
6.1 Pricing and Reimbursement in Netherlands
7 Distribution Structure
7.1 Distribution Structure in Netherlands
8 Drug Delivery Devices In Netherlands
8.1 Drug Delivery Devices, Netherlands, Overall Revenue ($ mn), 2000-2015
8.2 Drug Delivery Devices, Netherlands, Category Volume (Units), 2000-2015
8.3 Drug Delivery Devices, Netherlands, Company Share (2007-2008)
9 Infusion Systems In Netherlands
9.1 Infusion Systems Overall Revenue (2000-2015)
9.2 Infusion Systems Overall Volume (2000-2015)
9.3 Infusion Systems Average Price (2000-2015)
9.4 Infusion Systems Distribution Share (2007-2008)
9.5 Infusion Systems, Netherlands, Company Share (2007-2008)
10 Inhalation Systems In Netherlands
10.1 Inhalation Systems Overall Revenue (2000-2015)
10.2 Inhalation Systems Overall Volume (2000-2015)
10.3 Inhalation Systems Average Price (2000-2015)
10.4 Inhalation Systems Distribution Share (2007-2008)
10.5 Inhalation Systems, Netherlands, Company Share (2007-2008)
11 Overview of Key Companies in Netherlands Drug Delivery Devices Market
11.1 Terumo Corporation
11.1.1 Company Overview
11.2 Smiths Medical
11.2.1 Company Overview
11.3 Novartis AG
11.3.1 Company Overview
11.4 Hospira, Inc.
11.4.1 Company Overview
11.5 GlaxoSmithKline plc
11.5.1 Company Overview
11.6 Fresenius Kabi AG
11.6.1 Company Overview
11.7 Cardinal Health, Inc.
11.7.1 Company Overview
11.8 Boehringer Ingelheim GmbH
11.8.1 Company Overview
11.9 Consort Medical plc
11.9.1 Company Overview
11.9.2 Bespak plc Pipeline Products
11.9.2.1 Bespak plc Pipeline Products By Equipment Type
11.9.2.2 Bespak plc Pipeline Products By Development Stage
11.9.2.3 Bespak plc Pipeline Products By Therapy Area
11.10 Baxter International Inc.
11.10.1 Company Overview
11.11 B. Braun Melsungen AG
11.11.1 Company Overview
11.12 AstraZeneca PLC
11.12.1 Company Overview
11.13 Medisize B.V.
11.13.1 Company Overview
12 Recent Developments
12.1 Strategy And Business Planning
12.1.1 Jan 28, 2009: Philips Leads European ‘SonoDrugs’ Project To Develop Image-Guided Localized Drug Delivery Technologies
12.2 Product News
12.2.1 Jun 15, 2007: OptiNose Announces The Initiation Of Phase II Study In Chronic Rhinosinusitis
13 Appendix
13.1 Global Markets Direct Research Methodology
13.2 Secondary Research
13.3 Primary Research
13.4 Models
13.5 Forecasts
13.6 Expert Panel Validation
13.7 Currency Conversion
13.8 Contact Us
13.9 Disclaimer
1.1 List of Tables
Table 1: Healthcare Expenditure in Netherlands, 2000 - 2007
Table 2: Doctors by Specialty in Netherlands, 2000-2006
Table 3: Hospital Wards by Type in Netherlands, 2000-2006
Table 4: Drug Delivery Devices, Netherlands, Overall Revenue ($ mn), 2000-2015
Table 5: Drug Delivery Devices, Netherlands, Cross-Category Analysis, 2000-2015
Table 6: Drug Delivery Devices, Netherlands, Overall Revenue ($ mn), Historic, 2000-2008
Table 7: Drug Delivery Devices, Netherlands, Overall Revenue ($ mn), Forecast, 2008-2015
Table 8: Drug Delivery Devices, Netherlands, Category Volume (Units), 2000-2015
Table 9: Drug Delivery Devices, Netherlands, Category Volume (Units), Historic, 2000-2008
Table 10: Drug Delivery Devices, Netherlands, Category Volume (Units), Forecast, 2008-2015
Table 11: Drug Delivery Devices, Netherlands, Company Share by Revenue ($ mn), 2007-2008
Table 12: Infusion Systems, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 13: Infusion Systems, Netherlands, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 14: Infusion Systems, Netherlands, Volume (Units) by Segment, Historic, 2000-2008
Table 15: Infusion Systems, Netherlands, Volume (Units) by Segment, Forecast, 2008-2015
Table 16: Infusion Systems, Netherlands, Average Price ($), Historic, 2000-2008
Table 17: Infusion Systems, Netherlands, Average Price ($), Forecast, 2008-2015
Table 18: Infusion Systems, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
Table 19: Infusion Systems, Netherlands, Company Share by Revenue ($ mn), 2007-2008
Table 20: Inhalation Systems, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008
Table 21: Inhalation Systems, Netherlands, Revenue ($ mn) by Segment, Forecast, 2008-2015
Table 22: Inhalation Systems, Netherlands, Volume (Units) by Segment, Historic, 2000-2008
Table 23: Inhalation Systems, Netherlands, Volume (Units) by Segment, Forecast, 2008-2015
Table 24: Inhalation Systems, Netherlands, Average Price ($), Historic, 2000-2008
Table 25: Inhalation Systems, Netherlands, Average Price ($), Forecast, 2008-2015
Table 26: Inhalation Systems, Netherlands, Distribution Share by Revenue ($mn), 2007-2008
Table 27: Inhalation Systems, Netherlands, Company Share by Revenue ($ mn), 2007-2008
Table 28: Bespak plc Pipeline Products by Equipment Type
Table 29: Bespak plc Pipeline Products By Development Stage
Table 30: Bespak plc Pipeline Products By Therapy Area
Table 31: USD to Local Currency, Average Exchange Rate 2008
1.2 List of Figures
Figure 1: Total Healthcare Expenditure in Netherlands, 2000 - 2007
Figure 2: Government and Private Healthcare Expenditure in Netherlands, 2007
Figure 3: Healthcare Financing Framework in Netherlands, 2005
Figure 4: Flowchart for Classification of Non-invasive Devices in Netherlands, 2007
Figure 5: Flowchart for Classification of Invasive Devices in Netherlands, 2007
Figure 6: Flowchart for Classification of Invasive Devices in Netherlands, 2007
Figure 7: Flowchart for Classification of Invasive Devices in Netherlands, 2007
Figure 8: Flowchart for Classification of Invasive Devices in Netherlands, 2007
Figure 9: Flowchart for Classification of Active Devices in Netherlands, 2007
Figure 10: Flowchart for Classification of Active Devices in Netherlands, 2007
Figure 11: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Netherlands, 2007
Figure 12: Conformity Assessment of Class-I Medical Devices in Netherlands, 2007
Figure 13: Conformity Assessment of Class-IIa Medical Devices in Netherlands, 2007
Figure 14: Conformity Assessment of Class-IIb Medical Devices in Netherlands, 2007
Figure 15: Conformity Assessment of Class-III Medical Devices in Netherlands, 2007
Figure 16 Drug Delivery Devices, Netherlands, Overall Revenue ($ mn), 2000-2015
Figure 17: Drug Delivery Devices, Netherlands, Cross-Category Analysis, 2000-2015
Figure 18 Drug Delivery Devices, Netherlands, Overall Revenue ($ mn), Historic, 2000-2008
Figure 19 Drug Delivery Devices, Netherlands, Overall Revenue ($ mn), Forecast, 2008-2015
Figure 20 Drug Delivery Devices, Netherlands, Category Volume (Units), 2000-2015
Figure 21 Drug Delivery Devices, Netherlands, Category Volume (Units), Historic, 2000-2008
Figure 22 Drug Delivery Devices, Netherlands, Category Volume (Units), Forecast, 2008-2015
Figure 23 Drug Delivery Devices, Netherlands, Company Share (%), 2008
Figure 24 Infusion Systems, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008
Figure 25 Infusion Systems, Netherlands, Revenue ($ mn) by Segment, Forecast, 2008-2015
Figure 26 Infusion Systems, Netherlands, Company Share (%), 2008
Figure 27 Inhalation Systems, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008
Figure 28 Inhalation Systems, Netherlands, Revenue ($ mn) by Segment, Forecast, 2008-2015
Figure 29 Inhalation Systems, Netherlands, Volume (Units) by Segment, Historic, 2000-2008
Figure 30 Inhalation Systems, Netherlands, Volume (Units) by Segment, Forecast, 2008-2015
Figure 31 Inhalation Systems, Netherlands, Company Share (%), 2008
Figure 32 Global Markets Direct Methodology

Abstract

Netherlands Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Netherlands drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in Netherlands

Scope
  • The report provides information on the drug delivery devices market in Netherlands.
  • Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
  • Total revenues, products sold, end users, and average pricing.
  • Market shares of all the key competitors such as AstraZeneca International plc, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Novartis AG, and Bespak plc.
  • Key pipeline products that are set to shape the market, broken down by sector.
  • Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
  • Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
  • Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
  • Key mergers and acquisitions, partnerships, private equity investments and IPOs.
  • Customer, hospitals and physicians data.
Reasons to buy
  • Gain a strong understanding of the drug delivery devices market in Netherlands.
  • Evaluate and compare the attractiveness of the market in the country.
  • Identify growth segments and opportunities in each industry sector within the country.
  • Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
  • Analyze the competitiveness of the market in the country and identify hotspots.
  • Develop strategies based on the latest product, brand, expansion and research and development news in the country.
  • Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
  • Identify and analyze the strengths and weaknesses of the industry incumbents in the country.


Get Full Details About This Report >>
US: 800.298.5699
Int'l: +1.240.747.3093
Buy this Report
Price and Delivery Options
Search Inside Report


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

 

© MarketResearch.com 2009